News
Tariffs take a decisive back seat to a more pressing issue for Wall Street and investors.
Via The Motley Fool · April 30, 2025
The lender said the new stock repurchase program would take effect after its current plan expires.
Via Stocktwits · April 30, 2025
Powell, appointed as Fed chair by Trump during his first term, fell out of favor with the president after stating he would wait for more clarity on the effects of the administration's broad tariffs before adjusting interest rates.
Via Stocktwits · April 30, 2025
Spotify defended its $11.99 subscription price on its Q1 earnings call and signaled that price hikes are now a strategic option, as the company eyes long-term revenue growth despite rising inflation and stiff competition from Apple and YouTube Music.
Via Benzinga · April 30, 2025
Notwithstanding the resurgence seen since last week, the market is likely to end April with a monthly loss, with the S&P 500 down 0.90% with a session to go.
Via Stocktwits · April 29, 2025
Via The Motley Fool · April 29, 2025
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 34.9% in the pre-market session after Novo Nordisk announced plans to offer its weight loss drug Wegovy through the company's (Hims & Hers Health's) platform, expanding access to one of its fastest-growing products. By partnering with a popular telehealth company, Novo could speed up Wegovy's adoption, leading to more prescriptions. For investors, the deal signals a clear strategy to expand distribution and grab more market share, a move that could also boost sales growth for Hims & Hers (HIMS).
Via StockStory · April 29, 2025
Shares of identity management software maker Okta (OKTA)
jumped 8.9% in the afternoon session after S&P Dow Jones Indices announced the company would be added to the S&P MidCap 400 before trading opens on Thursday, May 1, 2025. Being included in the index means that Okta will likely be held by many mutual funds and ETFs, which could potentially drive up demand for the stock.
Via StockStory · April 29, 2025
Bitcoin (CRYPTO: BTC) is hovering near a major resistance level around $95,000. Analysts expect the upcoming Core PCE inflation report on Wednesday to be a potential catalyst that could push the apex crypto to new all-time highs.
Via Benzinga · April 29, 2025
Solomon also noted that policy actions to date have raised the level of uncertainty to a degree that isn’t healthy for investment and growth.
Via Stocktwits · April 29, 2025
Anyone who works with computers regularly knows typing can become repetitive while focused on a topic. Type4 offers a free text expander and snippet extension designed to help professionals save time and reduce typing requirements with fast, easy shortcuts built for modern workflows that work seamlessly across all websites.
Via Get News · April 29, 2025
Paulson also noted that, if faith in the U.S. dollar declines, gold is the best alternative as a reserve currency.
Via Stocktwits · April 29, 2025
American consumers are pessimistic about their financial future, with low expectations and concerns about inflation and job prospects under Trump.
Via Benzinga · April 29, 2025
Progressive Corp (PGR) stock underperforms S&P 500, but upgraded to Buy by analyst Joshua Shanker with a higher price target of $312 due to strong auto insurance growth and potential tariff-induced inflation.
Via Benzinga · April 29, 2025
Amazon clarified that although it considered displaying import charges on items sold through its site for ultra-discount items, the plan “was never approved and not going to happen.”
Via Stocktwits · April 29, 2025
Via The Motley Fool · April 29, 2025
As Financial Literacy Month draws to a close, it’s clear that understanding money management is more important than ever-especially given the economic
Via Equities.com · April 29, 2025
Gold holds above $3,300 amid easing trade tensions, Fed policy signals, and technical breakout momentum.
Via Talk Markets · April 29, 2025
TempoPay Rx to Provide Interest-Free Financing for Prescription Medications New Solution Designed to Mitigate Growing Trend in Medication non-Adherence Due to Cost
Via News Direct · April 29, 2025
Via The Motley Fool · April 29, 2025
Via The Motley Fool · April 29, 2025
Via The Motley Fool · April 29, 2025
The payments firm maintained its full-year guidance. PayPal stock fell on the news.
Via Investor's Business Daily · April 29, 2025